KLP Kapitalforvaltning
AMLX icon

KLP Kapitalforvaltning’s Amylyx Pharmaceuticals AMLX Stock Holding History

KLP Kapitalforvaltning’s Portfolio AMLX Stock Details AMLX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$591K Buy
20,300
+2,900
+17% +$76.9K ﹤0.01% 1390
2026
Q2 		$313K Hold
17,400
– – ﹤0.01% 1716
2026
Q1 		$242K Hold
17,400
– – ﹤0.01% 1746
2025
Q4 		$210K Buy
+17,400
New +$236K ﹤0.01% 1821

Other funds holding AMLX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.32T AUM 44.66% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $362B AUM 34.89% 1-Year Est. Return
Connor, Clark & Lunn Investment Management (CC&L)
Connor, Clark & Lunn Investment Management (CC&L) Vancouver, British Columbia, Canada $57.2B AUM 42.49% 1-Year Est. Return
Nuveen
Nuveen Charlotte, North Carolina $420B AUM 34.97% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return
Universal-Beteiligungs- und Servicegesellschaft
Universal-Beteiligungs- und Servicegesellschaft Frankfurt Am Main, Germany $65.3B AUM 33.78% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $500B AUM 36.84% 1-Year Est. Return
Moody Aldrich Partners
Moody Aldrich Partners Marblehead, Massachusetts $523M AUM 75.24% 1-Year Est. Return
Pictet Asset Management
Pictet Asset Management Carouge, Switzerland $106B AUM 32.76% 1-Year Est. Return

KLP Kapitalforvaltning's AMLX Position: Q3 2026 in Review

KLP Kapitalforvaltning increased its Amylyx Pharmaceuticals (AMLX) stake by 17% in Q3 2026, buying an estimated $76.9K and bringing the position to 20,300 shares worth $591K. The position accounts for ﹤0.01% of the portfolio, ranked #1390.

KLP Kapitalforvaltning first reported a position in AMLX in Q4 2025 and has held it in 4 quarters since. 88 funds tracked by Wall St. Rank hold AMLX as of Q3 2026.

  • KLP Kapitalforvaltning held 20,300 shares of Amylyx Pharmaceuticals worth $591K as of Q3 2026.
  • KLP Kapitalforvaltning bought 2,900 Amylyx Pharmaceuticals shares in Q3 2026, an estimated $76.9K.
  • Amylyx Pharmaceuticals made up ﹤0.01% of KLP Kapitalforvaltning's portfolio in Q3 2026, its #1390 holding.
  • KLP Kapitalforvaltning first reported a position in Amylyx Pharmaceuticals in Q4 2025 and has held it in 4 quarters since.
  • 88 funds tracked by Wall St. Rank held Amylyx Pharmaceuticals as of Q3 2026.

Based on KLP Kapitalforvaltning's 13F filing for Q3 2026, filed 10 Nov 2026.